Social Media Content Creators Driving Parallel Market for Unlicensed Weight-Loss Drug

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, marketing, and consumer regulations, risking penalties, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the platform has removed violative material and prohibited associated keywords and search suggestions. The organization stated it was dedicated to keeping the platform secure and investing in enhancing compliance measures.

Digital Marketplace Operations

Research also discovered communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of members, filled with images of slimming results, glowing reviews and detailed instructions for mixing or injecting at home.

Within minutes of joining one community, a vendor posted contact information, where most transactions take place. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, posts show dark colored packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for Telegram stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her staff has already encountered individuals harmed by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may subject users to potentially serious health risks”.

Darren Welch
Darren Welch

A seasoned gaming consultant with over a decade of experience in the industry, specializing in strategy development and customer support.